HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92 | -99.9% | 2,416 | -21.0% | 0.00% | – |
| Q4 2021 | $122,000 | +351.9% | 3,057 | +386.0% | 0.00% | – |
| Q4 2020 | $27,000 | -22.9% | 629 | -51.7% | 0.00% | – |
| Q2 2020 | $35,000 | -64.3% | 1,302 | -76.2% | 0.00% | -100.0% |
| Q1 2020 | $98,000 | -80.9% | 5,465 | -81.1% | 0.00% | -50.0% |
| Q4 2019 | $512,000 | +196.0% | 28,896 | +186.3% | 0.00% | +100.0% |
| Q2 2019 | $173,000 | -4.4% | 10,094 | -10.2% | 0.00% | 0.0% |
| Q1 2019 | $181,000 | -77.1% | 11,246 | -74.1% | 0.00% | -66.7% |
| Q3 2018 | $789,000 | -45.6% | 43,469 | -49.5% | 0.00% | -50.0% |
| Q2 2018 | $1,451,000 | -80.8% | 86,061 | -77.7% | 0.01% | -81.8% |
| Q1 2018 | $7,572,000 | +151340.0% | 386,420 | +188397.6% | 0.03% | – |
| Q2 2015 | $5,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |